Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with Phenylketonuria

Cardiovascular diseases are the main cause of mortality worldwide. Patients with phenylketonuria (PKU) may be at increased cardiovascular risk. This review provides an overview of clinical and metabolic cardiovascular risk factors, explores the connections between body composition (including fat mas...

Full description

Bibliographic Details
Main Authors: Luis M. Luengo-Pérez, Mercedes Fernández-Bueso, Ana Ambrojo, Marta Guijarro, Ana Cristina Ferreira, Luís Pereira-da-Silva, André Moreira-Rosário, Ana Faria, Conceição Calhau, Anne Daly, Anita MacDonald, Júlio César Rocha
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/15/24/5133
_version_ 1797379807987630080
author Luis M. Luengo-Pérez
Mercedes Fernández-Bueso
Ana Ambrojo
Marta Guijarro
Ana Cristina Ferreira
Luís Pereira-da-Silva
André Moreira-Rosário
Ana Faria
Conceição Calhau
Anne Daly
Anita MacDonald
Júlio César Rocha
author_facet Luis M. Luengo-Pérez
Mercedes Fernández-Bueso
Ana Ambrojo
Marta Guijarro
Ana Cristina Ferreira
Luís Pereira-da-Silva
André Moreira-Rosário
Ana Faria
Conceição Calhau
Anne Daly
Anita MacDonald
Júlio César Rocha
author_sort Luis M. Luengo-Pérez
collection DOAJ
description Cardiovascular diseases are the main cause of mortality worldwide. Patients with phenylketonuria (PKU) may be at increased cardiovascular risk. This review provides an overview of clinical and metabolic cardiovascular risk factors, explores the connections between body composition (including fat mass and ectopic fat) and cardiovascular risk, and examines various methods for evaluating body composition. It particularly focuses on nutritional ultrasound, given its emerging availability and practical utility in clinical settings. Possible causes of increased cardiometabolic risk in PKU are also explored, including an increased intake of carbohydrates, chronic exposure to amino acids, and characteristics of microbiota. It is important to evaluate cardiovascular risk factors and body composition in patients with PKU. We suggest systematic monitoring of body composition to develop nutritional management and hydration strategies to optimize performance within the limits of nutritional therapy.
first_indexed 2024-03-08T20:28:23Z
format Article
id doaj.art-ce9ac27dcf404e428794352d52b7a481
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-08T20:28:23Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-ce9ac27dcf404e428794352d52b7a4812023-12-22T14:30:18ZengMDPI AGNutrients2072-66432023-12-011524513310.3390/nu15245133Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with PhenylketonuriaLuis M. Luengo-Pérez0Mercedes Fernández-Bueso1Ana Ambrojo2Marta Guijarro3Ana Cristina Ferreira4Luís Pereira-da-Silva5André Moreira-Rosário6Ana Faria7Conceição Calhau8Anne Daly9Anita MacDonald10Júlio César Rocha11Biomedical Sciences Department, University of Extremadura, 06008 Badajoz, SpainClinical Nutrition and Dietetics Unit, Badajoz University Hospital, 06008 Badajoz, SpainClinical Nutrition and Dietetics Unit, Badajoz University Hospital, 06008 Badajoz, SpainClinical Nutrition and Dietetics Unit, Badajoz University Hospital, 06008 Badajoz, SpainReference Centre of Inherited Metabolic Diseases, Centro Hospitalar Universitário de Lisboa Central, Rua Jacinta Marto, 1169-045 Lisboa, PortugalCHRC—Comprehensive Health Research Centre, Nutrition Group, NOVA Medical School, Universidade Nova de Lisboa, 1349-008 Lisboa, PortugalNOVA Medical School (NMS), Faculdade de Ciências Médicas (FCM), Universidade NOVA de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, PortugalCHRC—Comprehensive Health Research Centre, Nutrition Group, NOVA Medical School, Universidade Nova de Lisboa, 1349-008 Lisboa, PortugalNOVA Medical School (NMS), Faculdade de Ciências Médicas (FCM), Universidade NOVA de Lisboa, Campo Mártires da Pátria 130, 1169-056 Lisboa, PortugalBirmingham Children’s Hospital, Birmingham B4 6NH, UKBirmingham Children’s Hospital, Birmingham B4 6NH, UKReference Centre of Inherited Metabolic Diseases, Centro Hospitalar Universitário de Lisboa Central, Rua Jacinta Marto, 1169-045 Lisboa, PortugalCardiovascular diseases are the main cause of mortality worldwide. Patients with phenylketonuria (PKU) may be at increased cardiovascular risk. This review provides an overview of clinical and metabolic cardiovascular risk factors, explores the connections between body composition (including fat mass and ectopic fat) and cardiovascular risk, and examines various methods for evaluating body composition. It particularly focuses on nutritional ultrasound, given its emerging availability and practical utility in clinical settings. Possible causes of increased cardiometabolic risk in PKU are also explored, including an increased intake of carbohydrates, chronic exposure to amino acids, and characteristics of microbiota. It is important to evaluate cardiovascular risk factors and body composition in patients with PKU. We suggest systematic monitoring of body composition to develop nutritional management and hydration strategies to optimize performance within the limits of nutritional therapy.https://www.mdpi.com/2072-6643/15/24/5133phenylketonuriabody compositionbody fatvisceral fatbioelectrical impedanceultrasound
spellingShingle Luis M. Luengo-Pérez
Mercedes Fernández-Bueso
Ana Ambrojo
Marta Guijarro
Ana Cristina Ferreira
Luís Pereira-da-Silva
André Moreira-Rosário
Ana Faria
Conceição Calhau
Anne Daly
Anita MacDonald
Júlio César Rocha
Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with Phenylketonuria
Nutrients
phenylketonuria
body composition
body fat
visceral fat
bioelectrical impedance
ultrasound
title Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with Phenylketonuria
title_full Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with Phenylketonuria
title_fullStr Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with Phenylketonuria
title_full_unstemmed Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with Phenylketonuria
title_short Body Composition Evaluation and Clinical Markers of Cardiometabolic Risk in Patients with Phenylketonuria
title_sort body composition evaluation and clinical markers of cardiometabolic risk in patients with phenylketonuria
topic phenylketonuria
body composition
body fat
visceral fat
bioelectrical impedance
ultrasound
url https://www.mdpi.com/2072-6643/15/24/5133
work_keys_str_mv AT luismluengoperez bodycompositionevaluationandclinicalmarkersofcardiometabolicriskinpatientswithphenylketonuria
AT mercedesfernandezbueso bodycompositionevaluationandclinicalmarkersofcardiometabolicriskinpatientswithphenylketonuria
AT anaambrojo bodycompositionevaluationandclinicalmarkersofcardiometabolicriskinpatientswithphenylketonuria
AT martaguijarro bodycompositionevaluationandclinicalmarkersofcardiometabolicriskinpatientswithphenylketonuria
AT anacristinaferreira bodycompositionevaluationandclinicalmarkersofcardiometabolicriskinpatientswithphenylketonuria
AT luispereiradasilva bodycompositionevaluationandclinicalmarkersofcardiometabolicriskinpatientswithphenylketonuria
AT andremoreirarosario bodycompositionevaluationandclinicalmarkersofcardiometabolicriskinpatientswithphenylketonuria
AT anafaria bodycompositionevaluationandclinicalmarkersofcardiometabolicriskinpatientswithphenylketonuria
AT conceicaocalhau bodycompositionevaluationandclinicalmarkersofcardiometabolicriskinpatientswithphenylketonuria
AT annedaly bodycompositionevaluationandclinicalmarkersofcardiometabolicriskinpatientswithphenylketonuria
AT anitamacdonald bodycompositionevaluationandclinicalmarkersofcardiometabolicriskinpatientswithphenylketonuria
AT juliocesarrocha bodycompositionevaluationandclinicalmarkersofcardiometabolicriskinpatientswithphenylketonuria